Drug Type Diagnostic radiopharmaceuticals |
Synonyms [18F]-LNC1007 |
Target |
Mechanism FAP modulators(Fibroblast activation protein alpha modulators), αvβ3 modulators(Integrin alpha-V/beta-3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | AU | 01 Sep 2024 | |
Diagnostic agents | IND Approval | CN | 20 Sep 2024 | |
Solid tumor | IND Approval | CN | 20 Sep 2024 |